Celldex Therapeutics (CLDX) Treasury Shares (2011 - 2019)
Celldex Therapeutics' (CLDX) quarterly Treasury Shares came in at $1110.0 in Q4 2019, down 68.75% year-on-year from $3552.0 in Q4 2018, and down 68.75% quarter-over-quarter from $3552.0 in Q4 2018.
Celldex Therapeutics (CLDX) Treasury Shares (2011 - 2019) Analysis & Trends
Celldex Therapeutics' Treasury Shares history runs 9 years deep, the most recent figure standing at $1110.0 for Q4 2019.
- On a quarterly basis, Treasury Shares fell 68.75% year-over-year to $1110.0 in Q4 2019; TTM through Dec 2019 was $1110.0, a 68.75% decrease from a year earlier, with the FY2019 full-year figure at $1110.0, down 68.75% from the prior year.
- Treasury Shares declined to $1110.0 in Q4 2019 per CLDX's latest filing, from $3552.0 in the prior quarter.
- Across five years, Treasury Shares topped out at $50000.0 in Q4 2016 and bottomed at $1110.0 in Q4 2019.
- The 5-year median for Treasury Shares is $6445.0 (2017), against an average of $16121.4.
- Across the five-year window, Treasury Shares jumped 178.57% in 2015 and slumped 87.11% in 2017, its largest moves.
- Year by year, Treasury Shares stood at $19500.0 in 2015, then surged by 156.41% to $50000.0 in 2016, then slumped by 87.11% to $6445.0 in 2017, then tumbled by 44.89% to $3552.0 in 2018, then slumped by 68.75% to $1110.0 in 2019.
- Per Business Quant, the three latest CLDX Treasury Shares figures stand at $1110.0 (Q4 2019), $3552.0 (Q4 2018), and $6445.0 (Q4 2017).
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Treasury Shares (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | -21,709.08 |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 265,401.92 |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | - |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | - |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 19.41 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | - |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 5.14 Mn |
| 10 | Celldex Therapeutics | 1.72 Mn | 1.72 Mn | -1.44 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2019 | 1,110.00 |
| Dec 31, 2019 | 1,110.00 |
| Dec 31, 2018 | 3,552.00 |
| Dec 31, 2018 | 3,552.00 |
| Dec 31, 2017 | 6,445.00 |
| Dec 31, 2017 | 6,445.00 |
| Dec 31, 2016 | 50,000.00 |
| Dec 31, 2016 | 50,000.00 |
| Dec 31, 2015 | 19,500.00 |
| Dec 31, 2015 | 19,500.00 |
| Dec 31, 2014 | 7,000.00 |
| Dec 31, 2014 | 7,000.00 |
| Dec 31, 2013 | 6,000.00 |
| Dec 31, 2013 | 6,000.00 |
| Dec 31, 2012 | 6,000.00 |
| Dec 31, 2012 | 6,000.00 |
| Jun 30, 2012 | 12,000.00 |
| Jun 30, 2012 | 12,000.00 |
| Dec 31, 2011 | 6,000.00 |
| Dec 31, 2011 | 6,000.00 |